P. Couppie, M. Sobesky, C. Aznar, S. Bichat, E. Clyti et al., Histoplasmosis and Acquired Immunodeficiency Syndrome: A Study of Prognostic Factors, Clinical Infectious Diseases, vol.38, issue.1, pp.134-138, 2004.
DOI : 10.1086/379770

B. H. Segal, J. D. Sobel, T. C. Sorrell, C. Viscoli, J. R. Wingard et al., Revised definitions of invasive fungal disease from the European Organization for 12 Research and Treatment of Cancer, Invasive Fungal Infections Cooperative Group and the 13 National Institute of Allergy and Infectious Diseases Mycoses Study Group 14 (EORTC/MSG) Consensus Group, pp.1813-1821, 2008.

C. Aznar, Characteristics and specificities of Cryptococcus infections in French 17, 2011.

G. Desoubeaux, E. Bailly, and J. Chandenier, Diagnosis of invasive pulmonary aspergillosis: Updates and recommendations, M??decine et Maladies Infectieuses, vol.44, issue.3, pp.89-101, 2014.
DOI : 10.1016/j.medmal.2013.11.006

URL : https://hal.archives-ouvertes.fr/inserm-00951150

G. Cimino, P. Martino, and C. Girmenia, Aspergillus galactomannan enzyme-linked 22 immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum, J. Clin. 23 Microbiol, vol.44, pp.3432-3434, 2006.

M. Rodgers, P. A. Connolly, B. Haddad, and L. J. Wheat, A multicenter evaluation 27 of tests for diagnosis of histoplasmosis, Clin. Infect. Dis, vol.53, pp.448-454, 2011.

Y. T. Huang, C. C. Hung, and P. R. Hsueh, Aspergillus galactomannan antigenemia in 29 penicilliosis marneffei, AIDS, vol.21, 1990.

. Histoplasma-capsulatum-var, capsulatum infection: 25 years experience of French Guiana. 33, AIDS, vol.22, pp.1047-1053

O. Jones, K. O. Cleveland, and M. S. Gelfand, A case of disseminated histoplasmosis following autologous stem cell transplantation for Hodgkin's lymphoma: an initial misdiagnosis with a false-positive serum galactomannan assay, Transplant Infectious Disease, vol.11, issue.3, pp.281-283, 2009.
DOI : 10.1111/j.1399-3062.2009.00381.x

C. A. Kauffman, Histoplasmosis: a Clinical and Laboratory Update, Clinical Microbiology Reviews, vol.20, issue.1, pp.115-132, 2007.
DOI : 10.1128/CMR.00027-06

C. A. Kauffman, Diagnosis of histoplasmosis in immunosuppressed patients, Current Opinion in Infectious Diseases, vol.21, issue.4, p.41, 2008.
DOI : 10.1097/QCO.0b013e328306eb8d

S. Moir and A. S. Fauci, B cells in HIV infection and disease, Nature Reviews Immunology, vol.90, issue.4, pp.235-245, 2009.
DOI : 10.1038/nri2524

S. Narreddy and P. H. Chandrasekar, False-positive Aspergillus galactomannan (GM) assay in histoplasmosis, Journal of Infection, vol.56, issue.1, pp.80-81, 2008.
DOI : 10.1016/j.jinf.2007.09.013

S. Ranque, R. Pelletier, A. Michel-nguyen, and F. Dromer, Platelia Aspergillus assay for diagnosis of disseminated histoplasmosis, European Journal of Clinical Microbiology & Infectious Diseases, vol.8, issue.3, pp.941-943, 2007.
DOI : 10.1007/s10096-007-0380-7

B. Sathapatayavongs, B. E. Batteiger, J. Wheat, T. G. Slama, and J. L. Wass, Clinical and Laboratory Features of Disseminated Histoplasmosis During Two Large Urban Outbreaks, Medicine, vol.62, issue.5, pp.263-270, 1983.
DOI : 10.1097/00005792-198309000-00001

S. Simon, V. Veron, R. Boukhari, D. Blanchet, and C. Aznar, Detection of Histoplasma capsulatum DNA in human samples by real-time polymerase chain reaction, Diagnostic Microbiology and Infectious Disease, vol.66, issue.3, pp.268-273, 2010.
DOI : 10.1016/j.diagmicrobio.2009.10.010

A. Therby, O. Polotzanu, D. Khau, S. Monnier, A. Greder-belan et al., Aspergillus galactomannan assay for the management of histoplasmosis due to 17, p.16, 2014.

. Histoplasma-capsulatum-var, duboisii in HIV-infected patients: Education from a clinical 18 case], J. Mycol. Med, vol.24, pp.166-170

A. M. Tobon, C. A. Agudelo, D. S. Rosero, J. E. Ochoa, C. De-bedout et al., Disseminated histoplasmosis: a 21 comparative study between patients with acquired immunodeficiency syndrome and non- 22 human immunodeficiency virus-infected individuals. Am, J. Trop. Med. Hyg, vol.73, pp.576-582, 2005.

K. B. Tong, C. J. Lau, K. Murtagh, A. J. Layton, and R. Seifeldin, The economic impact of 24 aspergillosis: analysis of hospital expenditures across patient subgroups, Int. J. Infect. Dis, vol.25, issue.13, pp.24-36, 2009.

P. Vergidis, R. C. Walker, D. R. Kaul, C. A. Kauffman, A. G. Freifeld et al., False-positive Aspergillus galactomannan assay in solid organ 31 transplant recipients with histoplasmosis, Transpl. Infect. Dis, vol.2012, issue.14, pp.213-217

L. J. Wheat, Antigen detection, serology, and molecular diagnosis of invasive mycoses 33 in the immunocompromised host. Transplant infectious disease : an official journal of the 34, Transplantation Society, vol.8, pp.128-139, 2006.

C. Hage, Histoplasmosis-associated cross-reactivity in the BioRad Platelia 37 Aspergillus enzyme immunoassay, Clin. Vaccine Immunol, vol.14, pp.638-640, 2007.

M. O. Xavier, A. C. Pasqualotto, I. C. Cardoso, and L. C. Severo, Cross-Reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus Species in the Commercial Platelia Aspergillus Enzyme Immunoassay, Clinical and Vaccine Immunology, vol.16, issue.1, pp.132-173, 2009.
DOI : 10.1128/CVI.00310-08